Our Workflow Solutions Empower Precision Medicine

The HTG EdgeSeq processor, assays, and parser software produce gene expression profiles from a wide variety of specimen types to accelerate discovery, support translational studies, and evaluate target biomarkers for companion diagnostic development.

Our solutions enable fast, reliable, reproducible, and quantitative analysis of thousands of targeted RNAs from a single assay in as little as 36 hours with reduced hands-on time.


  • Automated solutions quickly and reliably generate gene expression profiles 
  • A simple next-generation sequencing (NGS) library preparation workflow resulting in more reproducible results
  • Elimination of technically challenging steps reduces hands-on time 
  • Simple data analysis from an intuitive graphic user interface

Learn More 

Extraction-free chemistry

Our extraction-free chemistry significantly reduces sample input requirements and preserves valuable specimens.  The HTG EdgeSeq chemistry eliminates timely and technically challenging steps like cDNA synthesis, size selection, removal of rRNA, mRNA end repair, and adapter ligation.  

Our Simple, Easy-to-Use, Gene Expression Profiling Solution

The HTG EdgeSeq system is a powerful molecular profiling tool that provides an automated workflow solution.  The HTG EdgeSeq system is used with next-generation sequencing (NGS) instrumentation to produce gene expression profiles in as little as 36 hours.

HTG EdgeSeq Assays

Our multiplexed gene expression assays leverage the power and sensitivity of next-generation sequencing, allowing you to measure the expression levels of a few or thousands of genes with little sample input. HTG EdgeSeq assays generate results from clinically relevant samples, such as formalin-fixed, paraffin-embedded (FFPE) tissue, to support both research and diagnostic objectives.

HTG EdgeSeq CE-IVD Assays

Learn More

Learn more about HTG EdgeSeq Workflow.

Stay up to date on HTG Product, Service & Event announcements.

*Required field

Page last updated October 08, 2019